Ap­peals court quash­es Sanofi’s big win on bell­wether hair loss case

Sanofi thought it had emerged vic­to­ri­ous from the first case of thou­sands to go to tri­al over its chemother­a­py drug Tax­otere — but on Thurs­day, a fed­er­al ap­peals court over­turned that ju­ry ver­dict, or­der­ing a re­tri­al and turn­ing some heat on the phar­ma gi­ant.

This par­tic­u­lar law­suit was filed back in 2016 by Bar­bara Earnest, a breast can­cer sur­vivor who was treat­ed with sev­er­al rounds of chemother­a­py af­ter her lumpec­to­my, in­clud­ing Sanofi’s Tax­otere. While the treat­ments proved suc­cess­ful — Earnest was de­clared can­cer-free — her hair nev­er grew back.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER